Wednesday, 26 August 2026European Markets

POSTNL Stock Over 9% Down At Session Start Today

Loading stream...

(VIANEWS) - Shares of POSTNL (AEX-Index: PNL.AS) slid 9.57% to €1.64 at 10:10 EST on Monday, after five sequential sessions in a row of losses. AEX-Index is rising 1.22% to €755.50, after five successive sessions in a row of losses. This seems, at the moment, an all-around positive trend exchanging session today.

About POSTNL

PostNL N.V. provides postal and logistics services to businesses and consumers in the Netherlands, rest of Europe, and internationally. The company operates in two segments, Parcels, Mail in the Netherlands; and PostNL Other. It collects, sorts, transports, and delivers letters and parcels; and offers data and document management, direct marketing, and fulfillment services, as well as cross-border mail solutions. The company was formerly known as TNT N.V. and changed its name to PostNL N.V. in May 2011. PostNL N.V. is headquartered in the Hague, the Netherlands.

Earnings Per Share

As for profitability, POSTNL has a trailing twelve months EPS of €0.43.

PE Ratio

POSTNL has a trailing twelve months price to earnings ratio of 3.82. Meaning, the purchaser of the share is investing €3.82 for every euro of annual earnings.

Volatility

POSTNL's last week, last month's, and last quarter's current intraday variation average was a negative 1.08%, a negative 0.29%, and a positive 1.70%.

POSTNL's highest amplitude of average volatility was 1.08% (last week), 1.34% (last month), and 1.70% (last quarter).

More news about POSTNL (PNL.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com